Temocapril Hydrochloride – (110221-44-8)

957054-30-7, GDC-0941, PICTILISIB, Pictrelisib, GDC0941, GDC 0941, 4-(2-(1H-Indazol-4-yl)-6-((4-(methylsulfonyl)piperazin-1-yl)methyl)thieno[3, 2-d]pyrimidin-4-yl)morpholine, 2-(1H-Indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3, 2-d]pyrimidine, GDC-0941 (Pictilisib), Pictilisib (GDC-0941), ICY00EMP8P, Thieno[3, 2-d]pyrimidine, 2-(1H-indazol-4-yl)-6-[[4-(methylsulfonyl)-1-piperazinyl]methyl]-4-(4-morpholinyl)-, CHEBI:65326, CDC-0941, 957054-30-7 (free base), 2-(1H-Indazol-4-yl)-6-[[4-(methylsulfonyl)-1-piperazinyl]methyl]-4-(4-morpholinyl)thieno[3, 2-d]pyrimidine, 4-[2-(1H-indazol-4-yl)-6-[(4-methylsulfonylpiperazin-1-yl)methyl]thieno[3, 2-d]pyrimidin-4-yl]morpholine, 2-(1H-indazol-4-yl)-6-((4-(methanesulfonyl)piperazin-1-yl)methyl)-4-(morpholin-4-yl)thieno(3, 2-d)pyrimidine, 4-(2-(1H-indazol-4-yl)-6-((4-(methylsulfonyl)piperazin-1-yl)methyl)thieno(3, 2-d)pyrimidin-4-yl)morpholine, 2-(1H-indazol-4-yl)-6-{[4-(methylsulfonyl)piperazin-1-yl]methyl}-4-(morpholin-4-yl)thieno[3, 2-d]pyrimidine, 2-(1h-Indazol-4-Yl)-6-{[4-(Methylsulfonyl)piperazin-1-Yl]methyl}-4-Morpholin-4-Yl-Thieno[3, 2-D]pyrimidine, GD9, Thieno(3, 2-d)pyrimidine, 2-(1H-indazol-4-yl)-6-((4-(methylsulfonyl)-1-piperazinyl]methyl)-4-(4-morpholinyl)-, RG-7321, 957054-50-1, Pictilisib [USAN:INN], UNII-ICY00EMP8P, C23H27N7O3S2, THIENO(3, 2-D)PYRIMIDINE, 2-(1H-INDAZOL-4-YL)-6-((4-(METHYLSULFONYL)-1-PIPERAZINYL)METHYL)-4-(4-MORPHOLINYL)-, MFCD11616196, Kinome_3719, PICTILISIB [MI], GDC0941(Pictilisib), PICTILISIB [INN], Pictilisib (USAN/INN), PICTILISIB [USAN], GDC0941(Pictilisib)?, Pictilisib GDC-0941, PICTILISIB [WHO-DD], MLS006010057, SCHEMBL190812, CHEMBL521851, GTPL5682, BDBM25028, DTXSID40241930, EX-A167, LHNIIDJUOCFXAP-UHFFFAOYSA-N, HMS2043A16, HMS3244H06, HMS3244H10, HMS3244H14, HMS3265I05, HMS3265I06, HMS3265J05, HMS3265J06, HMS3654K13, HMS3744A19, BCP01714, EX-A1536, GNE 0941, NSC755385, NSC800852, RG7321, s1065, AKOS015966503, BCP9000715, CCG-264801, CS-0081, DB11663, FI32904, NSC-755385, NSC-800852, SB19941, SDCCGSBI-0654334.P001, NCGC00187482-01, NCGC00187482-03, NCGC00187482-10, 2-(1H-Indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3, 2-d]pyrimidine, AC-32623, AS-19377, HY-50094, SMR004701219, NS00071518, SW202556-4, D10189, A845396, Pictilisib (GDC0941, RG7321, GNE0941)), BRD-K52911425-001-02-3, BRD-K52911425-001-09-8, Q27088388, 2-(1H-Indazol-4-yl)-6-((4-(methylsulfonyl)piperazin-1-yl)methyl)-4-morpholinothieno[3, 2-d]pyrimidine Pictilisib, 2-(1H-indazol-4-yl)-6-{[4-(methylsulfonyl)piperazin-1-yl]methyl}-4-morpholin-4-ylthieno[3, 2-d]pyrimidine, 4-[2-(1H-indazol-4-yl)-6-[(4-methanesulfonylpiperazin-1-yl)methyl]thieno[3, 2-d]pyrimidin-4-yl]morpholine, 4-[2-(1H-indazol-4-yl)-6-[(4-methylsulfonyl-1-piperazinyl)methyl]-4-thieno[3, 2-d]pyrimidinyl]morpholine, 4-{6-[(4-methanesulfonylpiperazin-1-yl)methyl]-4-(morpholin-4-yl)thieno[3, 2-d]pyrimidin-2-yl}-2H-indazole